Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: ENOV ) 44.28 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Aug 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ENOV < Previous 1 2 3 4 Next > Enovis Beats Q1 Earnings Estimates, Raises 2023 Guidance May 04, 2023 Via Benzinga Enovis: Q1 Earnings Insights May 04, 2023 Via Benzinga Enovis Announces First Quarter 2023 Results May 04, 2023 From Enovis Corporation Via GlobeNewswire Earnings Outlook For Enovis May 03, 2023 Via Benzinga Enovis to Host First Quarter 2023 Results Conference Call on May 4th April 13, 2023 From Enovis Corporation Via GlobeNewswire Enovis to Acquire Novastep April 03, 2023 Strengthens Foot and Ankle Portfolio with Leading Minimally Invasive Surgery (MIS) Platform, including MIS Bunion System and Furthers Global Expansion Strategy From Enovis Corporation Via GlobeNewswire Analyst Ratings for Enovis October 26, 2022 Within the last quarter, Enovis (NYSE:ENOV) has observed the following analyst ratings: Via Benzinga Looking Into Enovis Return On Capital Employed August 18, 2022 Via Benzinga Top 5 Health Care Stocks That Preparing To Pump This Quarter March 29, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Enovis Announces Board Leadership Transition March 15, 2023 CEO Matt Trerotola to be named Chair and Director Sharon Wienbar to become Lead Independent Director following retirement of current Chair Mitchell P. Rales at 2023 Annual Meeting From Enovis Corporation Via GlobeNewswire ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting March 03, 2023 Medtech Leader Highlights Power of Collaboration in Its Continued Success and Innovation From Enovis Corporation Via GlobeNewswire Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023 February 27, 2023 From Enovis Corporation Via GlobeNewswire Enovis Announces Fourth Quarter and Full Year 2022 Results February 23, 2023 From Enovis Corporation Via GlobeNewswire Enovis to Host Fourth Quarter and Full Year 2022 Conference Call on February 23rd February 10, 2023 From Enovis Corporation Via GlobeNewswire Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023 February 08, 2023 With innovative offerings spanning across foot and ankle indications, Enovis will highlight its latest products including knotless suture anchors, bone fixation systems and disruptive NiTiNOL... From Enovis Corporation Via GlobeNewswire Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples January 17, 2023 Innovative new staples combine strength with unmatched, sustained dynamic compression for mid-foot and first MTP joint fusions From Enovis Corporation Via GlobeNewswire Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference January 05, 2023 From Enovis Corporation Via GlobeNewswire Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle December 01, 2022 The approval of the STAR PSI System marks an impactful milestone by allowing surgeons to provide a personalized pre-operative plan for their total ankle replacement patients From Enovis Corporation Via GlobeNewswire Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions November 17, 2022 Designed with our patented and proven NiTiNOL technology, DynaNail Helix™ revolutionizes dynamic compression in foot & ankle fusion From Enovis Corporation Via GlobeNewswire Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting November 10, 2022 From Enovis Corporation Via GlobeNewswire Recap: Enovis Q3 Earnings November 02, 2022 Enovis (NYSE:ENOV) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Enovis beat estimated earnings by... Via Benzinga Enovis Announces Third Quarter 2022 Results November 02, 2022 From Enovis Corporation Via GlobeNewswire Enovis to Participate in Investor Conferences in November October 28, 2022 From Enovis Corporation Via GlobeNewswire Enovis to Host Third Quarter 2022 Conference Call on November 2nd October 13, 2022 From Enovis Corporation Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 October 12, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 October 11, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022 September 12, 2022 Upgrades Via Benzinga Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery July 19, 2022 From Enovis Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 June 28, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022 June 16, 2022 Upgrades Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.